EMA database update: novelties for XEVMPD and PMS, expiry dates and support for MA holders
The European Medicine Agency (EMA) has introduced some important novelties for the management of drug regulatory data, starting the switch...
The European Medicine Agency (EMA) has introduced some important novelties for the management of drug regulatory data, starting the switch...
The latest update of the Ministry of Health guideline on MD, IVD and PMC (Presidi Medico Chirurgici, medical surgical aids)...
Professionals still search in the internet for the biocidal products directive (Directive 98/8/EC). Today, however, the European regulatory framework is...
Pharmacovigilance applied to social network refers to the collection and monitoring of any report of adverse reactions to drugs or...
R4BP3 (Register for Biocidal Products – version 3) is the electronic portal developed by ECHA (European Chemicals Agency) for the management of...
In the complex regulation landscape of medical devices (MDs) and in vitro diagnostics (IVDs), regulatory assistance represents a crucial element...
Whoever deals with medical device, has to face this question sooner or later: what is ISO 13485? It is an...
Pharmacovigilance in the European Union Over the years, pharmacovigilance has become a fundamental topic for pharmaceutical companies, which are required...
Delegated Regulation (EU) 2016/161 of the European Commission (integrating Directive 2001/83/EC of the European Parliament and of the Council) provides...
In the latest years, the sector of medical devices (MD) and in vitro diagnostics (IVD) underwent important regulatory and organisation...
Headquarter
Legal Office
Sede di Milano
© 2021 Di Renzo® s.r.l.
Sede legale: Viale Manzoni 59 – 00185 Roma
Sede operativa: Via dell’Arco di Travertino 11 – 00178 Roma
+39 0677209020 - P. Iva 07227271009 - Cookies Policy - Trattamento dei dati
© Copyright 2025 Di Renzo Regulatory Affairs. All Rights Reserved by Di Renzo Regulatory Affairs